AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

All

Events(319)

Highlight(127)

Highlighted publications(69)

News(58)

Highlighted publication

The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis.

Wischnewski V, Guerrero Aruffo P, Massara M, (…), Maas RR, Soukup K, Joyce JA

Cell reports – 2025 Mar 25

Highlighted publication

Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study.

Banerjee S, Ghisoni E, Wolfer A, (…), Coens C, Dangaj Laniti D, Coukos G

Clinical cancer research – 2025 Mar 18

Highlighted publication

Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors.

Bejarano L, Lourenco J, Kauzlaric A, (…), Daniel RT, Hegi ME, Joyce JA

Immunity – 2025 Mar 18

Highlight

Prof. Douglas Hanahan Receives Pezcoller-AACR Award

Events

Ludwig Distinguished Lecture, Prof. Crystal Mackall | March 27th

More information

Events

AGORA PRS Seminar | April 1st

More information

Events

Oncology Grand Rounds, Prof. Chantal Berna Renella | March 28th

More information

Events

Inaugural lecture, Prof. Fernanda Herrera | April 1st

More information

Events

Life Sciences BioCore Seminar Series on advanced cellular models | April 3

More information

Events

PhD Thesis Defense | April 4th

More information

Events

Lola and John Grace Distinguished Lecture in Cancer Research, Dr. Céline Vallot | April 7th

More information

Highlighted publication

Magnetic bead-sensitized optoporation coupled with antibodies-based activation for mRNA CAR-T cell manufacturing

Maldonado-Pérez N, Doucey MA, Dzhumashev D, (…), Henry L, Dutoit V, Migliorini D

Molecular Therapy – 2025 Mar 13

Past news

Latest publications

The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis.

Wischnewski V, Guerrero Aruffo P, Massara M, (…), Maas RR, Soukup K, Joyce JA

Cell reports – 2025 Mar 25

T cell receptor precision editing of regulatory T cells for celiac disease.

Porret R, Alcaraz-Serna A, Peter B, (…), Pantaleo G, Sollid LM, Muller YD

Science translational medicine – 2025 Mar 19

Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors.

Bejarano L, Lourenco J, Kauzlaric A, (…), Daniel RT, Hegi ME, Joyce JA

Immunity – 2025 Mar 18

Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study.

Banerjee S, Ghisoni E, Wolfer A, (…), Coens C, Dangaj Laniti D, Coukos G

Clinical cancer research – 2025 Mar 18

Deleterious knock-outs in the HLA class I antigen processing and presentation machinery induce distinct changes in the immunopeptidome.

Shapiro IE, Maschke C, Michaux J, (…), Verkerk T, Spaapen R, Bassani-Sternberg M

Molecular & cellular proteomics – 2025 Mar 18